About the Authors

Matthieu Dusselier

Roles Conceptualization, Investigation, Writing – original draft

matthieu.dusselier@gmail.com

Affiliation Service de Pneumologie, CHU, Limoges, France

Elise Deluche

Roles Project administration

Affiliation Service d’Oncologie Médicale, CHU, Limoges, France

Nellie Delacourt

Roles Writing – review & editing

Affiliation Service de Pneumologie, CHU, Limoges, France

Julia Ballouhey

Roles Writing – review & editing

Affiliation Service de Pneumologie, CHU, Limoges, France

Thomas Egenod

Roles Resources

Affiliation Service de Pneumologie, CHU, Limoges, France

Boris Melloni

Roles Writing – review & editing

Affiliation Service de Pneumologie, CHU, Limoges, France

Charlotte Vergnenègre

Roles Resources, Writing – review & editing

Affiliation CHU Bordeaux, service des maladies respiratoires, Bordeaux, France

Rémi Veillon

Roles Resources

Affiliation CHU Bordeaux, service des maladies respiratoires, Bordeaux, France

Alain Vergnenègre

Roles Investigation, Supervision

Affiliation Service de Pneumologie, CHU, Limoges, France

Competing Interests

The authors have read the journal’s policy and the authors of this manuscript have the following competing interests: TE is a paid advisory board member for Bristol-Myers Squibb, Merck-Sharp and Dohme, and Hoffmann-La Roche. RV is a paid expert for Bristol-Myers Squibb and Merck-Sharp and Dohme. He received honoraria from Bristol-Myers Squibb, and Merck-Sharp and Dohme for consultancy and board membership, and received reimbursement for congress registration from Bristol-Myers Squibb and Merck-Sharp and Dohme outside the present study. AV is a paid expert board member for Bristol-Myers Squibb, Merck-Sharp and Dohme, and Hoffmann-La Roche. He received honoraria from Bristol-Myers Squibb, Merck-Sharp and Dohme, Hoffmann-La Roche, Pierre Fabre Oncologie, and AstraZeneca for consultancy and board membership. AV also received reimbursement for congress registration from Pierre Fabre Oncologie and AstraZeneca outside the present study. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.